Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Citigroup Maintains Sell on Nevro, Lowers Price Target to $8.2

Author: Benzinga Newsdesk | July 10, 2024 09:13pm
Citigroup analyst Joanne Wuensch maintains Nevro (NYSE:NVRO) with a Sell and lowers the price target from $9 to $8.2.

Posted In: NVRO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist